Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2010
06/09/2010CN101224231B Method of extracting immunologic adjuvant component from cochinchina momordica seed
06/09/2010CN101007168B SARS vaccine and its preparation method
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732578 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences; converting an antibody sequence of any subject species to a less immunogenic form
06/08/2010US7732577 Isolated antibody specific for a mammalian MDM2 binding protein comprising SEQ ID No. 2 or 4
06/08/2010US7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis
06/08/2010US7732567 Methods and compositions for modulating and detecting wisp activity
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732563 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
06/08/2010US7732462 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/08/2010US7732423 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
06/08/2010US7732400 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
06/08/2010US7732188 Protozoan strains of reduced virulence and use thereof
06/08/2010US7732130 Immunoprotective influenza antigen and its use in vaccination
06/08/2010US7731980 Polymorphic membrane proteins (pmp), amino acid and nucleotide sequences, antibodies specific for polymorphic membrane proteins, polypeptides, prophylactic and therapeutic compositions
06/08/2010US7731979 Protective antigen having fluorinated histidine residues
06/08/2010US7731978 nontoxic oxygen labile streptolysin protein induces an immune response against Streptococcus pyogenes
06/08/2010US7731977 treating pruritis associated with psychosis by local administration; skin itching, hallucinations obsessive compulsive disorders treated by low dose, intramuscular administration of botulinum toxin
06/08/2010US7731976 treating irritable bowel syndrome using a probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium; carrier medium include fructo-oligo-saccharides; dose form in a capsule
06/08/2010US7731975 Chimeric filovirus glycoprotein
06/08/2010US7731974 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector
06/08/2010US7731973 Administering estriol to treat multiple sclerosis, autoimmune diseases, psoriasis, Sjogren's syndrome, encephalomyelitis; inflammatory bowel, Crohn's, Hashimoto's, or Addison's disease; diabetes, myasthenia gravis, lupus, rheumatoid arthritis, polymyositis; immunotherapy; magnetic resonance imaging
06/08/2010US7731972 comprising a fusion product of at least the extracellular part of a conserved influenza membrane protein other than the rapidly changing hemagglutinin and/or neuraminidase
06/08/2010US7731971 for use in second generation HIV vaccines and as diagnostic tools in the treatment and control of HIV infection; define a critical balance between MHC affinity and receptor crossreactivity required for effective epitope enhancement and also demonstrate construction and efficacy of
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010US7731969 Methods for developing and producing antigen-specific antibody-producing cells
06/08/2010US7731968 Topical delivery of vaccines
06/08/2010US7731967 Compositions for inducing immune responses
06/08/2010US7731966 Monoclonal antibodies against β3 integrins
06/08/2010US7731965 brain natriuretic peptide (BNP); not subject to preotease cleavage
06/08/2010US7731964 Comprises immunoglobulin which binds insulin receptors when phosphorylated at serine 1101 and/or 1149; for diagnosing insulin-resistance diabetes and insulin transport disorders
06/08/2010US7731963 modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists
06/08/2010US7731962 Anti-ADDL monoclonal antibody and use thereof
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010US7731960 cell growth inhibitors for pancreatic cancer
06/08/2010US7731959 Antagonists of neuropilin receptor function and use thereof
06/08/2010US7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
06/08/2010US7731951 Viruses for the treatment of cellular proliferative disorders
06/08/2010US7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010US7731939 Killed cells of Mycobacterium avium as immunogens and mineral oil; immunocontraceptive vaccines such as gonadotropin releasing hormone (GnRH)
06/08/2010US7731937 Diagnostic method for paratuberculosis
06/08/2010CA2388063C Cytotoxic agents comprising taxanes and their therapeutic use
06/08/2010CA2363991C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/03/2010WO2010063033A2 Recombinant avian influenza vaccine and uses thereof
06/03/2010WO2010062955A1 Treating neoplasms with neurotoxin
06/03/2010WO2010062904A2 Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
06/03/2010WO2010062859A2 Recombinantly expressed plasmodium celtos antigen and methods of use thereof
06/03/2010WO2010062858A1 Il-17 antibody inhibitor for treating dry eye
06/03/2010WO2010062857A1 Klk-13 antibody inhibitor for treating dry eye
06/03/2010WO2010062815A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
06/03/2010WO2010062814A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
06/03/2010WO2010062757A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents
06/03/2010WO2010062742A2 Methods for freparation and use of marrow infiltrating lymphocytes (mils)
06/03/2010WO2010062401A2 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010WO2010062399A2 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010WO2010062396A2 Virus like particle compositions and methods of use
06/03/2010WO2010062143A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
06/03/2010WO2010061930A1 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
06/03/2010WO2010061924A1 Avian influenza vaccine
06/03/2010WO2010061919A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
06/03/2010WO2010061899A1 Transformed soybean plant which stores vaccine, and use thereof
06/03/2010WO2010061360A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
06/03/2010WO2010061359A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine
06/03/2010WO2010061358A1 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
06/03/2010WO2010061357A1 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
06/03/2010WO2010061193A2 Compositions with reduced dimer formation
06/03/2010WO2010060972A1 Erk1/2 phosphorylation site specific antibody
06/03/2010WO2010060921A1 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
06/03/2010WO2010060768A1 Polypeptides, antibody variable domains & antagonists
06/03/2010WO2010060632A1 Promoters for recombinant viral expression
06/03/2010WO2010060614A1 Method and system for building a phylogeny from genetic sequences and using the same for recommendation of vaccine strain candidates for the influenza virus
06/03/2010WO2010060430A2 Optimized influenza vaccines
06/03/2010WO2010060208A1 Peptide adjuvants
06/03/2010WO2010060186A1 Antibodies that specifically block the biological activity of a tumor antigen
06/03/2010WO2010037514A3 Novel immunotherapy against several tumors including neuronal and brain tumors
06/03/2010WO2010036293A8 Malaria vaccine
06/03/2010WO2010033863A3 Vaccine compositions of m2e, ha0 and bm2 multiple antigenic peptides
06/03/2010WO2010027729A3 Gonococcal vaccines
06/03/2010WO2010027501A3 Anti-lipid antibodies
06/03/2010WO2010023452A3 Nematode vaccine
06/03/2010WO2010019276A3 Method and formulation for treating adverse biological conditions
06/03/2010WO2010006060A3 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
06/03/2010WO2009151697A9 Compositions and processes relating to human bocavirus
06/03/2010US20100138945 Humanized anti-il-6 antibodies
06/03/2010US20100137976 Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors
06/03/2010US20100137219 Methods and Compositions for Inhibiting Binding IgE to a High Affinity Receptor
06/03/2010US20100137192 Compositions and methods for treating or ameliorating mycobacterial infections
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136568 Compositions and Methods for Regulating RNA Translation via CD154 CA-Dinucleotide Repeat
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136099 Liposome for induction of cell-mediated immunity
1 ... 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 ... 1823